What MoCRA actually requires
The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) gave FDA expanded authority over cosmetic products sold in the United States for the first time in decades. If you're a formulator, indie founder, or brand preparing to launch, MoCRA compliance isn't optional paperwork — it determines whether your product can legally enter US commerce. Below is a breakdown of the core obligations, but because FDA has continued to issue guidance and adjust enforcement timelines since 2022, always confirm current deadlines and requirements directly on fda.gov before you launch.
Facility registration and product listing
Under MoCRA, any facility that manufactures or processes cosmetic products for US distribution must register with FDA, and each product must be listed through FDA's Cosmetics Direct electronic portal. This applies whether you manufacture in-house or use a contract manufacturer — responsibility for registration can fall on the manufacturer, but the Responsible Person must ensure listing happens. Facilities generally must renew registration every two years, and product listings should be updated when formulas change materially.
Who counts as the Responsible Person
MoCRA requires every cosmetic product to have a designated Responsible Person — the manufacturer, packer, or distributor whose name appears on the label. This entity is legally accountable for ensuring the product is not adulterated or misbranded, for maintaining safety substantiation, and for handling adverse event reports.
Adverse event recordkeeping and reporting
The Responsible Person must keep records of adverse events associated with the product for six years (three years for small businesses). Serious adverse events — those involving death, hospitalization, significant disfigurement, or similar outcomes — must be reported to FDA within 15 business days of receipt. Any new material information about that event received afterward must also be submitted to FDA within 15 business days of receipt.
Safety substantiation and labeling
MoCRA requires that cosmetic products have "adequate substantiation" of safety, meaning tests, studies, research, or other evidence a qualified expert would consider sufficient to support that the product is safe for its intended use. There is no single prescribed test list — the substantiation standard depends on the product type and claims, which is why many brands bring in a cosmetic chemist or regulatory consultant to review their safety file before launch.
Labels must also include a domestic US address, phone number, or website where consumers can report adverse events — this is a direct MoCRA labeling requirement, separate from any existing FDA cosmetic labeling rules on ingredient declarations and net quantity.
Rules still being finalized
As of this writing, FDA's cosmetic Good Manufacturing Practice (GMP) regulations and fragrance-allergen labeling disclosure requirements mandated by MoCRA were still moving through the rulemaking process and had not been fully finalized. Deadlines and specific requirements for both can change, so check fda.gov for the current status before finalizing your compliance plan.
Small business exemption — and its exceptions
MoCRA includes a small-business exemption from facility registration, product listing, and GMP requirements for businesses with average gross annual US sales of cosmetics under $1 million over the prior three years. However, this exemption does not apply to manufacturers of certain higher-risk product categories, including products that regularly come into contact with the eye area, are injected, are intended for internal use, or are intended to alter appearance for more than 24 hours (for example, certain hair-smoothing or semi-permanent products). Brands in these categories must comply with registration and listing requirements regardless of revenue.
| Requirement | Who it applies to | Key detail |
|---|---|---|
| Facility registration | Manufacturers/processors | Via FDA Cosmetics Direct; renew every 2 years |
| Product listing | Responsible Person | Update when formula changes materially |
| Adverse event reporting (serious) | Responsible Person | Report within 15 business days |
| Recordkeeping | Responsible Person | 6 years (3 years for small business) |
| Safety substantiation | All cosmetic products | No fixed test list; expert-based standard |
| Label contact info | All cosmetic products | US address, phone, or website required |
| Small-business exemption | Under ~$1M avg annual US sales (3 yrs) | Exceptions for eye-contact, injectable, internal-use, >24hr appearance-altering products |
Why founders use the AJ Cosmo Labs app
Preparing for MoCRA compliance usually means pulling together a formula, safety documentation, and the right expert input in one place. The AJ Cosmo Labs iPhone app is built for that kind of coordination before you take a product to market:
- Post a brief describing your product and compliance needs, and receive proposals from approved chemists and regulatory experts
- Use Formulate, the in-app AI formula generator, to draft a starting formula with full ingredient breakdown, percentages, and phases
- Run an AI regulatory compliance check as a first-pass decision aid, then send the formula to an admin-approved cosmetic chemist for review and validation
- Browse the formula marketplace for ready-made, IP-licensed formulas instead of starting from zero
- Message chemists, labs, and manufacturers directly and keep payments in escrow, released by milestone
- Track proposals and get push updates as your project moves forward
An AI-generated formula or compliance check inside the app is a starting point, not a substitute for a qualified chemist's review — especially for anything tied to safety substantiation or label claims.
Getting expert help before you launch
Because MoCRA's safety substantiation standard and the still-finalizing GMP and fragrance-allergen rules leave room for interpretation, many founders bring in a regulatory consultant or cosmetic chemist rather than guessing. On AJ Cosmo Labs, approved chemists and regulatory experts can help a brand prepare its formula documentation, safety file, and label language — they don't replace your own confirmation of current FDA deadlines, but they can cut down the back-and-forth of figuring out what applies to your specific product.
Download AJ Cosmo Labs to get started
If you're preparing to sell cosmetics in the US and need to line up a chemist, manufacturer, or regulatory expert who understands MoCRA, download AJ Cosmo Labs from the App Store and post your first brief today. You can also reach the same marketplace through the full web app at app.ajcosmolabs.com, but the iOS app is where most founders track proposals, message providers, and move a formula from draft to compliant product.
Frequently asked questions
What is MoCRA and why does it apply to my cosmetic brand before I sell in the US?
MoCRA is the Modernization of Cosmetics Regulation Act, signed into law in December 2022, which fundamentally changed how the FDA regulates cosmetics in the United States. It applies to any cosmetic product manufactured for sale, distribution, or use in the US — whether you're a small indie founder making your first batch or an established brand. Before MoCRA, the FDA had minimal pre-market authority over cosmetics; companies could launch products with minimal regulatory oversight. MoCRA shifted that model by requiring companies to register their facilities, list their products with the FDA, submit safety substantiation data, and maintain detailed records. If you're selling cosmetics in the US without complying with MoCRA, your products are technically in violation of federal law, and the FDA can issue warning letters, import alerts, or take enforcement action. The law applies to all products that meet the cosmetics definition under the Federal Food, Drug, and Cosmetic Act: articles intended to be applied to the body for cleansing, beautifying, promoting attractiveness, or altering appearance. This includes skincare, haircare, makeup, fragrances, sunscreens (note: sunscreen is regulated as a drug, not a cosmetic), deodorants, and most personal care products. The only exception is if your product makes a therapeutic or disease-treating claim — in that case, it's classified as a drug and faces even stricter FDA oversight. MoCRA also introduced new requirements around microbial limits, stability testing, and adverse event reporting that didn't exist before. For indie founders and small brands, MoCRA means you cannot simply manufacture a formula and sell it online or in retail without first navigating registration, listing, labeling, and safety documentation. This is why many founders partner with chemists and contract manufacturers who understand MoCRA compliance — getting it wrong can result in your inventory being seized or held at US ports. AJ Cosmo Labs connects indie founders with vetted cosmetic chemists and contract manufacturers who are familiar with MoCRA requirements and can guide you through the registration and safety substantiation process before your first bottle ships. Many chemists on the platform have experience preparing dossiers and working with brands through FDA compliance.
What are the key MoCRA compliance steps I need to complete before selling cosmetics in the US?
MoCRA compliance breaks down into five core steps, and you must complete them before your first sale: facility registration, product listing, safety substantiation, labeling compliance, and adverse event monitoring setup. Many founders skip or rush through these steps, assuming they're optional or can be done after launch — that's the most common and costly mistake. First, you must register your manufacturing facility with the FDA. If you're using a contract manufacturer or co-packer, they handle the facility registration; if you're manufacturing yourself, you register your own facility. Registration happens through the FDA's electronic submission system and requires your facility name, address, emergency contact, and a description of the cosmetics you make. You must renew your facility registration every two years between June and December. If you fail to register, the FDA can refuse entry of your products at US ports, and retailers will not accept unregistered-facility products. Second, you must list each individual cosmetic product with the FDA. Product listing differs from facility registration: listing identifies the specific cosmetic (e.g., "Lavender Face Cream" or "Charcoal Shampoo") and requires you to provide the product's identity, responsible party contact information (the company legally responsible for compliance), and ingredients. You list products through the same FDA system after your facility is registered. Each product SKU or formulation variant typically requires its own listing. This must happen before the product is sold in the US. Third, you must have safety substantiation data for your product. MoCRA requires that cosmetics be "safe under conditions of use." What that means in practice is you need evidence that your formula, at the concentrations used, will not cause unreasonable risk of harm. For many indie brands, this takes the form of a cosmetic safety assessment — a document prepared by a qualified cosmetic chemist or toxicologist that reviews the ingredients, their hazard profiles, the exposure pathway (topical application, rinse-off vs. leave-on, frequency of use), and concludes whether the product is safe. The assessment might include stability testing data (real-time or accelerated), microbiological testing, compatibility studies between ingredients, and a literature review of the safety of each component. You do not always need to conduct expensive clinical trials, but you must have documented justification for why your formula is safe. This is where working with a vetted chemist on AJ Cosmo Labs becomes critical — they know how much safety data you actually need and what level of rigor satisfies FDA expectations for your product category and price point. Fourth, your label must comply with MoCRA labeling rules. Labels must include the ingredient declaration in INCI (International Nomenclature of Cosmetic Ingredients) format in descending order of concentration, the net quantity of contents, the manufacturer or distributor name and address, and a warning statement if required. Additionally, any claims on your label ("anti-aging," "moisturizing," "strengthens hair") must be substantiated — the same way you'd substantiate safety. If your label says a product "reduces fine lines," you need data supporting that claim. Many indie brands fail compliance here by using unsubstantiated language or forgetting required elements like the responsible party statement. Fifth, you must establish a process to receive, track, and report adverse events. MoCRA introduced mandatory adverse event reporting: if a consumer reports that your cosmetic caused an injury, skin irritation, hair loss, or other harm, you must document it and report it to the FDA if it involves serious injury or if certain criteria are met. You need a system — even just an email address and a spreadsheet — to log complaints, and you must retain records for at least three years. The timeline for these steps typically runs 2–4 months before your first sale if you have all your data ready. Facility registration takes 1–2 weeks after submission. Product listing takes 2–4 weeks. Safety substantiation and label compliance can happen in parallel with registration but require input from your chemist and should be completed before listing. AJ Cosmo Labs allows you to hire a chemist on the platform who can review your formula for MoCRA safety substantiation and advise on labeling requirements — a second expert review reduces the risk of errors.
What safety data and documentation do I need to include in my MoCRA product listing?
MoCRA does not require you to submit safety data directly to the FDA at the time of product listing, but it does require that you have documented safety substantiation available and can produce it upon FDA request. This is a critical distinction: the FDA does not have a central database of all cosmetic safety studies, but the agency expects you to retain a safety file and provide it during an inspection or in response to a warning letter. If you cannot produce the safety substantiation when asked, your product can be deemed adulterated or misbranded. The core of your safety file is a cosmetic safety assessment (CSA), also called a cosmetic product safety file. This is typically a 20–50 page document prepared by a qualified cosmetic chemist or toxicologist that includes: a description of the product and its intended use, a complete ingredient list with INCI names and concentrations, a hazard assessment of each ingredient (toxicity profile, concentration thresholds of concern, regulatory status in other regions), an assessment of the formula's safety under conditions of use (considering age group, frequency of application, skin type, body area where applied), review of any stability or compatibility issues, and a conclusion that the product is safe. For leave-on products applied to sensitive skin or used on children, the CSA is more rigorous. For rinse-off products (shampoos, body washes), the bar is typically lower because exposure is limited. You do not always need to conduct costly third-party testing to have a defensible CSA. Many smaller brands rely on a literature-based safety assessment: your chemist reviews published studies on each ingredient, consults toxicology databases (like HSDB or PubChem), and compares the concentration in your formula to the no-effect level documented in the literature. If your lavender fragrance is used at 0.5% and published data shows lavender oil is safe at concentrations up to 5%, your chemist can justify safety without additional testing. However, if an ingredient is novel, used at an unusually high concentration, or combined with other actives in a way that hasn't been studied, your chemist will likely recommend stability testing or microbiological testing to fill that gap. Stability testing data strengthens your safety file. Stability testing assesses whether a formula degrades, separates, discolors, or develops microbial growth over time. A common protocol (though not a legal requirement — the right protocol depends on your product and market) involves storing samples at 40 °C and 75% relative humidity for 8–12 weeks, then testing them for appearance, odor, viscosity, pH, and microbial load. Real-time stability testing at room temperature for 6–12 months is more rigorous but takes longer. If your product is supposed to last 12 months on a shelf, you need data or justification showing it won't degrade or become contaminated during that period. Without stability data, the FDA may question how you can claim the product is safe for the entire shelf life you're listing. Microbiological testing is often required or strongly recommended for water-containing cosmetics (creams, lotions, serums). The test checks for bacterial and fungal contamination. USP or pharmacopeial standards (typically <100 CFU/g for aerobic bacteria, <10 CFU/g for molds and yeasts) are common thresholds, but the specific limits should be justified based on product type and intended use. If your product is preservative-free and water-based, expect higher scrutiny and potentially higher microbiological limits if you can justify them with published literature. Due diligence on raw material safety is also part of the file. You should maintain Certificates of Analysis (CoAs) from your ingredient suppliers showing that each raw material meets its specification and is free of harmful contaminants. If you're using botanical extracts or essential oils, CoAs confirming the botanical identity and purity add credibility. If an ingredient has been flagged by regulatory bodies (e.g., the EU has restricted or banned it), your file should document why it's safe for use in the US or why it doesn't apply to your formula. Several FDA guidance documents outline expectations for safety data, particularly the 2016 guidance on cosmetic safety assessment (before MoCRA) and the 2023 MoCRA implementation guidance. Both emphasize that safety assessment is a science-based, risk-proportionate process — you invest more in data for products with higher risk (leave-on, sensitive populations) and less for lower-risk products (rinse-off, adult use). An approved chemist on AJ Cosmo Labs can help you determine what level of safety substantiation your specific product actually needs and to prepare a defensible file that won't trigger FDA concerns during inspection.
How much does MoCRA compliance cost, and what are the main cost drivers?
MoCRA compliance costs vary dramatically depending on product type, formula complexity, and what data you already have. A simple, single-ingredient rinse-off product (like a basic shampoo) might cost $1,500–$3,500 to bring into compliance, while a complex multi-active leave-on skincare cream with novel ingredients can exceed $10,000–$20,000. The largest cost drivers are safety substantiation, stability testing, and legal or consulting support. Breaking down the main cost elements: a cosmetic safety assessment (CSA) prepared by a qualified chemist or toxicologist typically runs $800–$3,000 depending on formula complexity and whether it requires literature review only or includes testing coordination. A simple rinse-off product with common ingredients (surfactants, preservatives, EDTA) might require 4–6 hours of chemist time ($800–$1,500). A leave-on skincare product with actives, botanical extracts, or novel ingredients will need 8–15 hours ($1,600–$3,000 or more). Stability testing adds significant cost: accelerated stability testing (40 °C / 75% RH for 8–12 weeks) costs $500–$1,500 per test batch, depending on the lab and the parameters measured. Real-time stability testing can run $1,500–$3,000+ because it spans months. Microbiological testing (aerobic plate count, mold and yeast) typically costs $300–$800 per batch. If your formula contains a new or unusual ingredient, or if you're making claims ("anti-inflammatory," "brightening") that go beyond traditional cosmetic claims, claim substantiation testing or sensory studies can add $1,000–$5,000. Clinical trials for high-end skincare brands can cost $5,000–$25,000+, but they're not mandatory for MoCRA compliance — only if you're making therapeutic or disease-treatment claims that blur into drug territory. Label development and compliance review by a regulatory consultant costs $300–$1,000 per product. FDA facility registration itself is free, and product listing is free; the costs are in the substantiation and preparation work. If you're hiring a regulatory consultant or law firm to oversee your entire MoCRA implementation, expect $2,000–$10,000 in consulting fees, particularly if you have multiple SKUs or complex formulas. Here's how cost varies by product type: a rinse-off haircare product with a standard silicone or protein conditioner will likely need only a literature-based CSA and basic stability data, totaling $1,500–$3,000. A leave-on moisturizer or serum with natural extracts and a preservative system will need a more thorough CSA, stability testing, and microbiological testing, totaling $2,500–$6,000. An anhydrous (water-free) product like a solid body scrub or lip balm has lower microbiological risk, so costs drop to $1,200–$3,000. A sunscreen falls into the drug category (separate from cosmetics) and requires much more rigorous testing, potentially $5,000–$15,000+. One critical cost-saving strategy is working with your chemist or manufacturer early. If your formula is designed with MoCRA compliance in mind — using well-studied ingredients at reasonable concentrations, with a validated preservative system — the cost of substantiation is much lower than if you develop a formula first and then scramble to justify it. A chemist on AJ Cosmo Labs can advise during formulation whether your ingredient choices will require expensive testing or can be justified through literature. This front-loaded guidance typically saves 30–50% on downstream compliance costs. Another common mistake is underestimating the cost of multiple SKUs. If you launch five different shades of lipstick or five fragrance variants, you typically need to list each as a separate product and conduct separate stability testing for each if the formulas differ. This multiplies costs quickly. Many small brands initially list only their core SKU and add variants later after launch costs are recouped. For indie founders bootstrapping, the minimum viable compliance budget is $1,500–$2,500 for a single, straightforward rinse-off product (CSA plus one round of stability testing). For a leave-on product, budget $3,000–$5,000. If you're launching multiple SKUs or complex formulations, plan for $5,000–$10,000 upfront. One option is to hire a single vetted chemist on AJ Cosmo Labs at a fixed project fee to prepare the whole compliance package (safety assessment, testing coordination, label review) rather than coordinating several vendors yourself.
What happens if I sell cosmetics in the US without MoCRA compliance, and what are the FDA enforcement risks?
Selling cosmetics in the US without MoCRA compliance is a violation of federal law, and the FDA has significant enforcement authority under the Modernization of Cosmetics Regulation Act. Enforcement action can range from a warning letter to product seizure, import detention, and legal prosecution in severe or repeat cases. Understanding the realistic risks will help you prioritize compliance before launch. The most common first step is an FDA warning letter. If the agency becomes aware of a non-compliant cosmetic — through social media monitoring, consumer complaints, import inspections, or industry tips — they send a letter detailing the violations and requesting corrective action within a specified timeframe (usually 15 days). Common violations include failure to register the facility, failure to list the product, missing or incomplete ingredient labeling, and lack of safety substantiation. A warning letter does not immediately halt sales, but it creates a legal record of non-compliance. If you ignore it or don't remedy the violations, enforcement escalates. A warning letter also damages credibility: retailers see it and may refuse to stock your product, and the letter is public (posted on the FDA website), affecting brand reputation and consumer trust. Product seizure is a more serious enforcement action. If the FDA finds that a cosmetic is adulterated or misbranded (e.g., lacks a required ingredient statement or can't produce safety data), federal marshals can seize inventory at manufacturing facilities, warehouses, or retail locations. Your products are then held in government custody, and you must prove compliance or they're destroyed. Seizure can happen at the border if your product arrives in a US port — many indie brands manufacturing overseas discover this when their shipment is held and they're asked to provide facility registration, product listings, and safety data within days. If you can't produce these documents immediately, the shipment is refused entry and may be returned to the origin or destroyed. Import detention is another critical risk for brands manufacturing outside the US. If the FDA has reason to believe a product violates MoCRA, they can place an import alert on that product or facility, meaning every shipment is detained for FDA review before entry. This can delay product arrival by weeks or even months and is extremely costly for small inventory runs. A single detained shipment can wipe out profit margins for an indie founder. Adverse event reporting violations carry their own penalties. If a consumer reports that your cosmetic caused skin irritation or injury and you fail to document and report it to the FDA when required, you're in violation. The FDA can issue a warning letter or fine. More importantly, if your product causes genuine harm and you haven't been tracking adverse events, your liability exposure increases dramatically — a personal injury lawsuit will reveal that you had no safety file and no adverse event monitoring system. Label and claim violations are frequently cited. If your label includes unsubstantiated claims (e.g., "clinically proven to reduce wrinkles" without supporting data) or missing required elements (no ingredient declaration, no net quantity, no manufacturer address), the FDA treats this as misbranding. Even if your formula is safe, a label violation is a violation, and it can be the reason your product is held at import or your shipment is refused. The practical consequences for indie founders are severe. A single warning letter or import detention can exhaust your cash reserves, delay launch by months, and force you to reformulate or abandon the product entirely. If you've pre-sold to customers or retailers, a seized shipment creates legal liability and reputational damage. Additionally, FDA enforcement actions are public and searchable online — a warning letter against your brand is discovered by investors, retail partners, and future customers, making it difficult to rebuild trust. Regional and marketplace complications arise as well. Amazon, Sephora, Ulta, and other major retailers require proof of FDA compliance (facility registration and product listing numbers) before they'll accept your product. If you can't provide these, you're restricted to smaller independent retailers, beauty boxes, or direct-to-consumer sales. International shipping is also complicated: Canada, the EU, and Australia have their own cosmetics regulations (Health Canada's Natural and Non-prescription Health Products Directorate, the EU's banned-substance list, TGA in Australia), and products non-compliant with US MoCRA may also fail in these markets. The most common scenario for indie founders is discovering non-compliance too late — after inventory has been manufactured or even after some sales. At that point, the cost and timeline to achieve compliance retroactively is much higher. A chemist on AJ Cosmo Labs can help you audit your current compliance status and create a remediation plan if you're already in this position, but proactive compliance before manufacturing always costs less and poses far lower risk. If you're still in the formulation or pre-manufacturing phase, work with a vetted chemist to design for compliance from day one.
What labeling requirements and ingredient declarations must I follow under MoCRA?
MoCRA labeling requirements cover ingredient declaration, warning statements, responsible party identification, and compliance with claim substantiation rules. Many indie founders undershoot on label compliance, assuming that a pretty design and a basic ingredient list are sufficient — in reality, missing or incorrect label elements are one of the most common FDA violations and can result in product seizure or a warning letter. The ingredient declaration is the foundation. You must list all ingredients in INCI (International Nomenclature of Cosmetic Ingredients) format in descending order of concentration. This means if your shampoo is 35% water, you list it first as "Aqua" (INCI for water), then the next most concentrated ingredient, and so on. Ingredients below 1% concentration can be listed in any order after the 1% threshold. The list must appear on the label in clear, legible type (typically 8-point font or larger, though the regulation allows some flexibility for small containers). You cannot use brand names or common names; you must use the INCI designation, which you can find in the International Cosmetic Ingredient Dictionary maintained by the Personal Care Products Council. One critical nuance: trade secret ingredients and fragrance/flavor components have limited disclosure rights under FDA regulation. If your formula includes a proprietary conditioning complex or a unique preservative blend, you can still declare it by its INCI name without revealing the exact sub-components — but the declaration must be transparent enough for consumer safety. Fragrance and flavor ingredients can be declared as "Fragrance" or "Flavor" as a single ingredient without listing each aromatic compound, because formula transparency for fragrance is not required by cosmetics law (though it is in the EU). If you use the catch-all "Fragrance," any essential oils, aroma molecules, or fragrance compounds in your formula roll up under that single declaration. The responsible party statement must appear on the label. This is a statement that reads "Manufactured for [Brand Name]" or "Distributed by [Brand Name]" followed by the company name, street address, city, state, and ZIP code. This identifies who is legally responsible for the product's compliance. If you're using a contract manufacturer, the label often says "Manufactured for [Your Brand] by [Manufacturer Name and Address]" or just lists your brand's responsible party. The responsible party is also the contact the FDA reaches out to if there's a compliance issue. This address must be a physical street address, not a PO box. The net quantity of contents must be declared in both metric and US customary units (e.g., "Net Wt. 2 oz (56 g)" for a powder or "Net Vol. 8 fl oz (237 mL)" for a liquid). This must be on the principal display panel (the front of the package) and must be in clear, conspicuous type. For very small packages (under 1 fluid ounce or 30 grams), the net quantity can sometimes be omitted or reduced in size, but check current FDA guidance for your specific product. Warning statements and precautionary language are required for certain products. If your cosmetic poses a foreseeable hazard, you must include a warning statement. For example: "For external use only. Avoid contact with eyes. If irritation occurs, discontinue use and consult a physician." The specificity of the warning depends on the product. A leave-on facial serum might require "Avoid contact with eyes; if contact occurs, rinse thoroughly with water." A rinse-off shampoo might need "For external use only." If your product is intended for use on children, warnings about swallowing and adult supervision are common. Sunscreens (which are drugs, not cosmetics) have specific warning language mandated by the FDA. Claim substantiation is closely tied to labeling. Any claim you make on the label or marketing materials (website, social media, packaging) must be substantiated. Claims fall into several tiers: establishment claims (e.g., "moisturizes skin") are generally acceptable for leave-on moisturizers because they're inherent to the product's function. Structure-function claims (e.g., "supports healthy skin barrier") require substantiation but don't require clinical trials for typical cosmetics — literature review and ingredient-level evidence often suffice. Disease-treatment or drug claims (e.g., "reduces acne," "treats eczema," "heals wounds") automatically classify your product as a drug, not a cosmetic, and require much stricter FDA oversight, clinical trials, and pre-market approval. A common mistake is using language that crosses from cosmetic to drug: saying "eliminates wrinkles" is a drug claim, but "reduces the appearance of fine lines" is typically acceptable as a cosmetic claim. The distinction hinges on whether you're claiming the product actually treats or cures a condition (drug) versus enhancing appearance (cosmetic). The label must also list any allergens or sensitizing ingredients if they're present above a threshold or if industry standards recommend disclosure. For example, if your formula contains fragrance, many brands declare "May cause allergic contact dermatitis" or list common fragrance allergens (limonene, linalool, eugenol) because fragrance allergies are common. This is not always legally required, but it's a best practice and demonstrates care for consumer safety. Manufacturing date, expiration date, and lot/batch codes are not required on cosmetics labels by the FDA (unlike drugs or foods), but many brands include them for consumer convenience and to support recall efforts if needed. If you do include an expiration date, you must have supporting data (stability testing) showing the product is unsafe or ineffective beyond that date. For small packages (under 20 square inches of label space), the FDA allows a "squeeze" of the principal label information onto the packaging and the rest onto the package insert or outer carton. For example, a lip balm tube might fit only the brand name and net quantity on the front; the full ingredient list and responsible party can appear on the back or on a box insert. However, the responsible party and net quantity are considered essential and must appear on the product itself if there's any space — they can't be on an insert only. Label compliance is checked during FDA inspections and import reviews. A poorly labeled product is one of the fastest ways to get held at the border or flagged in a warning letter. Working with a vetted chemist or regulatory expert through AJ Cosmo Labs to review your label before manufacturing ensures you include all required elements, use correct INCI names, make only substantiated claims, and avoid common mistakes. Many indie founders redesign labels once or twice before manufacture to incorporate compliance feedback — it's much cheaper to fix a label design than to deal with a product seizure due to missing ingredient declarations or unsubstantiated claims.
Do I need MoCRA compliance if I'm selling cosmetics only outside the US, or if I'm making products for personal use only?
MoCRA applies only to cosmetics manufactured, packaged, labeled, or held for sale in the United States or intended for distribution in the US market. If you're manufacturing cosmetics solely for sale in Canada, the EU, Australia, or other non-US markets, US MoCRA does not apply to those products — but those regions have their own cosmetics regulations that you must comply with instead. If you're selling on Amazon or Shopify globally, even if your primary market is non-US, products that can be purchased and shipped to the US must comply with MoCRA, because the intent to distribute in the US is established by your sales channel. Personal-use exemptions are extremely narrow. If you're making cosmetics only for yourself and not selling, trading, or distributing them, MoCRA does not apply. However, as soon as you give a product to a friend, trade it for something else, sell it, or offer it as a sample, it becomes a "cosmetic for sale" under FDA jurisdiction. Many indie founders believe that small-batch production for friends or family avoids MoCRA — this is incorrect and a common misunderstanding. Once you've established a pattern of distribution (even gifts) or if you've ever received payment or barter, the FDA can classify your activity as manufacturing cosmetics for distribution, triggering compliance obligations. If someone gets injured from a product you made, even if it was a gift, you may face liability. Custom cosmetics made-to-order for a single customer occupy a gray area. Some custom cosmetics labs and formulators have argued that a cosmetic made specifically for one person under a one-time order is not "for sale" in the traditional sense and may fall outside MoCRA. However, the FDA has not issued blanket guidance confirming this exemption, and enforcement action has targeted some custom cosmetics services. If you're operating a custom cosmetics business (e.g., bespoke perfume or foundation matching), you should assume MoCRA applies and work toward compliance. Custom cosmetics services can also hire vetted chemists through AJ Cosmo Labs to review their formulas and prepare the safety documentation FDA may ask to see. Cross-border sales and marketplace implications are crucial. If you manufacture a cosmetic in Canada or India and sell it to US customers via an online marketplace, it becomes a US-distributed product and must comply with MoCRA — regardless of where it's manufactured. US Customs and Border Protection will detain products that lack facility registration and product listings. Additionally, major US marketplaces (Amazon, Shopify, Etsy, Sephora) increasingly require proof of MoCRA compliance (facility registration number and product listing number) before accepting cosmetics for sale, even if technically a single-unit shipment to a US customer might avoid enforcement. It's much simpler to achieve compliance upfront than to deal with account suspension or product delisting. Regional regulation differences mean you need to understand the compliance landscape for each market. The EU Cosmetics Regulation (EC 1223/2009) is far more restrictive than MoCRA — it maintains a banned substance list of over 1,300 ingredients (versus the FDA's much shorter list), requires pre-market safety assessment, and mandates that all products be registered in the CPNP (Cosmetics Products Notification Portal). If you're selling in both the US and EU, you may need two different formulations or you'll have to reformulate to meet the EU's stricter standards and then sell that version in the US too. Canada's Natural and Non-prescription Health Products Directorate (NHPD) has its own approval process for certain cosmetic categories (anti-dandruff shampoos, sunscreens, certain skincare products). Australia's TGA regulates sunscreens and some therapeutic goods separately. Japan's MFDS and Korea's MFDS have different banned lists and ingredient restrictions. A strategic approach for indie founders is to design and manufacture to the most restrictive standard that applies to your target markets. If you're selling in the EU and US, formulate and substantiate to EU standards; if you're also in Canada, adopt the most conservative approach across all three. This simplifies supply chain management and avoids the cost of maintaining multiple formulations. AJ Cosmo Labs can connect you with chemists who understand multi-regional compliance and can guide you through formulation choices that satisfy MoCRA, EU regulations, and other key markets in a single product line. The bottom line: if there's any possibility your cosmetic will reach a US consumer — whether through your own sales, a distributor, a marketplace, or even samples sent to US influencers — assume MoCRA applies and plan for compliance. Claiming "I'm only selling to Australia" does not protect you if your product is accessible to a US customer and you knew or should have known that US sales were possible. Working with a vetted chemist early to understand your compliance obligations across all intended markets prevents costly reformulations and regulatory setbacks later.